Close Menu

Genalyte

NEW YORK (GenomeWeb News) – Genalyte today said that it has inked an agreement with the Barbara Davis Center for Childhood Diabetes at the University of Colorado School of Medicine to collaborate on the further development of multiplexed antigen panels for the early detection of T1D.

Researchers at the Polytechnic Institute of New York University have developed a biosensor capable of label-free detection of single proteins.

Quest Diagnostics this week released two tests for the diagnosis of rheumatoid arthritis based on the 14-3-3eta protein.

NEW YORK (GenomeWeb News) – Genalyte today announced it has inked distribution deals for its Maverick Detection System covering parts of Europe.
The system, which analyzes multiple antibodies and other proteins, also received the CE Mark for research use in Europe.

In addition to seeking research customers interested in using its platform for multiplex analysis, Genalyte is now accelerating development of its own internal content around autoimmune disease and diabetes.

NEW YORK (GenomeWeb News) – Multiplex assay development firm Genalyte today announced it has been awarded a $500,000 Small Business Innovation Research grant to develop multiplexed diagnostic assays for the early detection and monitoring of type 1 diabetes.

NanoString Technologies this week launched an application for single-cell gene-expression profiling.

NEW YORK (GenomeWeb News) – Multiplex assay developer Genalyte said today that it will market Scienion's automated liquid dispensers with its Maverick Detection System.

Proteome Sciences this week introduced its new MS3 mass spectrometry workflow using its TMT isobaric tagging reagents.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Genalyte today announced the completion of a Series B financing that raised $11.8 million.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.